Social networks
1,036Activities
Technologies
Entity types
Location
All. des Palanques, 33127 Saint-Jean-d'Illac, France
Saint-Jean-d'Illac
France
Employees
Scale: 51-200
Estimated: 12
SIREN
433860103Engaged corporates
0Added in Motherbase
3 years, 2 months agoGalenix, a Key pharmaceutical R&D partner, helps you to reduce your timeline by offering innovative solutions
DRUG DELIVERY SOLUTIONS - DRUG PRODUCT DEVELOPMENT - LICENSING-OUT OPPORTUNITIES
Galenix provides a range of full R&D pharmaceutical services and Drug Delivery Solutions to health companies for fast access of their products on the market.
●●● From the sourcing of the API through the Drug Product development process, including preformulation, formulation, to clinical supplies, quality control, ICH stabilities and regulatory dossier submission for Europe and US FDA registration.
Galenix provides its customers drug products “ready to launch” holding a Marketing Authorization.
●●● Galenix Innovations includes 6 different innovative technology platforms focusing on drug delivery solutions for life cycle management, new chemical entities and Biologicals using conventional medicinal presentations or its own patented technologies.
« Patients are central to our approaches »
Galenix team is focusing to preserve and/or to increase market shares on products through differentiation in accordance with regulations.
drug product development, drug delivery solutions, licensing-out opportunities, and Pharmaceutical development consulting
Galenix, a Key pharmaceutical R&D partner, helps you to reduce your timeline by offering innovative solutions
DRUG DELIVERY SOLUTIONS - DRUG PRODUCT DEVELOPMENT - LICENSING-OUT OPPORTUNITIES
Galenix provides a range of full R&D pharmaceutical services and Drug Delivery Solutions to health companies for fast access of their products on the market.
●●● From the sourcing of the API through the Drug Product development process, including preformulation, formulation, to clinical supplies, quality control, ICH stabilities and regulatory dossier submission for Europe and US FDA registration.
Galenix provides its customers drug products “ready to launch” holding a Marketing Authorization.
●●● Galenix Innovations includes 6 different innovative technology platforms focusing on drug delivery solutions for life cycle management, new chemical entities and Biologicals using conventional medicinal presentations or its own patented technologies.
« Patients are central to our approaches »
Galenix team is focusing to preserve and/or to increase market shares on products through differentiation in accordance with regulations.
GALENIX INNOVATIONS, innovative technology platform focusing on Drug Delivery Solutions for Life Cycle Management, New Chemical Entities, Biologicals or Mature Molecules using conventional dosage forms or its own patented technologies.